Skip to content

Effect of Bicycle Ergometer Training on Fat Tissue Amount and Metabolism

Effect of Bicycle Ergometer Training in Thermoneutral and Lightly Cold Ambient Temperatures on Fat Tissue Amount and Metabolism in Overweight and Obese Women

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07263126
Enrollment
36
Registered
2025-12-04
Start date
2025-05-27
Completion date
2026-04-27
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endurance Training

Keywords

Bicycle Ergometer, Overweight, Obese

Brief summary

The aim of this study is to investigate the effect of endurance training performed with a bicycle ergometer at different ambient temperatures on the amount of fat tissue and fat tissue metabolism in overweight and obese women.

Detailed description

This study will examine the effects of 12 weeks of endurance training on a bicycle ergometer at thermoneutral and slightly cold ambient temperatures on body composition, subcutaneous and visceral fat tissue thickness, and levels of irisin, leptin, adiponectin, apelin, IL-6 and FGF-21 in the blood of overweight and obese women.

Interventions

OTHERendurance training with bicycle ergometer in termoneutral ambient temperature

trained with bicycle ergometer three times a week for three months.

OTHERendurance training with bicycle ergometer in lightly cold ambient temperature

trained with bicycle ergometer three times a week for three months.

Sponsors

Pamukkale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The main outcome measures will be assessed by 3 different researchers . The researchers conducting the assessments will not know which group the participants are belongs to.

Intervention model description

Endurance training in termoneutral ambient, Endurance training in lightly cold ambient, control group (the waiting list group)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Being female, * Being between 20-40 years old, * Having a BMI between 25 and 34.9, * Having a waist circumference greater than 80 cm, * Not having participated in any exercise program in the last 3 months , * Not having experienced a change of more than 10% in body weight in the last 6 months.

Exclusion criteria

* On a weight loss diet, * Having cancer, unstable heart disease, cerebrovascular disease, metabolic disease, diabetes, hypertension, psychiatric disorders, or other conditions or neurological disorders, * Having a musculoskeletal disorder or any disease/injury that may affect participation in exercise training, * Participating in regular physical activity (at least 150 minutes of moderate-intensity physical activity or 75 minutes of vigorous-intensity physical activity or an equivalent combination of both during the week), * Being pregnant or breastfeeding, * Having undergone surgery for the treatment of obesity, * Receiving pharmacological treatment for obesity. Participants who did not attend more than 20% of the endurance training program will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
rate of BMIbaseline/ through study completion, an average 3 monthsassesed with height and body weight
analysis of biyoelectric impedans Bioelectrical impedance analysisbaseline/ through study completion, an average 3 monthsassesed with with a Tanita BC 418 brand device.
Waist circumference Waist hip ratiobaseline/ through study completion, an average 3 monthsWaist circumference will be measured with a tape measure.
rate of subcutaneous and visceral adipose tissue thicknessbaseline/ through study completion, an average 3 monthsassesed with Ultrasonography
concentration of serum irisinbaseline/ through study completion, an average 3 monthsassesed with blood analysis
concentration of serum adiponectinbaseline/ through study completion, an average 3 monthsassesed with blood analysis
concentration of serum apelinbaseline/ through study completion, an average 3 monthsassesed with blood analysis
concentration of serum IL-6baseline/ through study completion, an average 3 monthsassesed with blood analysis

Countries

Turkey (Türkiye)

Contacts

STUDY_DIRECTORUmmuhan Baş Aslan, Prof. Dr.

Prof. Dr.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026